Learn more about the relationship between multiple myeloma and kidney failure. Information on their links, causes, symptoms, diagnosis, treatment, and outlook.

Researchers at the University of Alabama at Birmingham have discovered a way to prevent kidney failure from occurring in people with multiple myeloma. Paul Sanders, M.D., a nephrologist in the ...

CAR T-cell therapy targeting B-cell maturation antigen (BCMA) has become a game changer for patients with relapsed or ...

Multiple myeloma (MM) is a clonal B-cell disease of slowly proliferating plasma cells, accompanied by monoclonal protein production and lytic bone lesions. Up to 50 per cent of newly diagnosed ...

Plasmapheresis is an uncommon treatment that can be used to manage something called myeloma kidney, a type of kidney failure that affects many people with multiple myeloma.It separates out plasma ...

Renal failure is a frequent complication in patients with multiple myeloma (MM) that causes significant morbidity. In the majority of cases, renal impairment is caused by the accumulation and ...

Of all cancer subtypes, multiple myeloma conferred the greatest risk for kidney failure (aHR = 18.97); this was followed by leukemia, lymphoma, kidney cancer, ovarian cancer and liver cancer.

Renal failure in multiple myeloma; presenting features and predictors of outcomes in 94 patients from a single institution. Arch Intern Med 1998; 158: 1889–1893.

Untreated, multiple myeloma can cause kidney damage or failure, bone fractures, cardiac arrest, or coma. The prognosis of ...

Symptoms of kidney failure include: Shortness of breath; Weakness; Swelling in your legs; Itching; Your Doctor May Suspect Multiple Myeloma Before You Do. Sometimes, doctors find signs of multiple ...

Pomalidomide plus low-dose dexamethasone improved responses among patients with relapsed/refractory multiple myeloma and moderate to severe renal impairment, according to results from a phase 2 ...

Cite this: Reversibility of Renal Impairment in Patients With Multiple Myeloma Treated With Bortezomib-based Regimens: Identification of Predictive Factors - Medscape - Aug 01, 2009. Abstract and ...